Martin Konrad Ostermaier

Title: Martin Ostermaier: Innovator in GPCR Research

Introduction

Martin Ostermaier is a notable inventor based in Waldshut-Tiengen, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of G protein-coupled receptors (GPCRs). His innovative methods have advanced the understanding of ligand binding at a molecular level.

Latest Patents

Ostermaier holds a patent titled "Method for determining mutateable ligand-GPCR binding at single amino acid resolution and pairs of mutated ligand and GPCR." This patent outlines a method for determining the binding ability of GPCRs and mutateable ligands. The process involves using a microtiter plate with an array of wells containing GPCR or rhodopsin, along with parent ligand mutants. By contacting these mutants with GPCR, the binding strength of the mutants compared to the standard parent ligand can be determined. This method has led to the development of functional maps that reveal critical interactions within the arrestin polar core and C-tail during activation.

Career Highlights

Ostermaier is affiliated with the Paul Scherrer Institut, where he conducts his research. His work has been instrumental in creating a model for the arrestin-rhodopsin complex, which is crucial for understanding GPCR-ligand interactions. His innovative approach allows for modifications in binding affinity and GPCR-ligand complex stability, which can be applied in diagnostics or therapeutic interventions.

Collaborations

Ostermaier has collaborated with esteemed colleagues such as Gebhard Schertler and Joerg Standfuss. Their combined expertise has further enriched the research landscape in GPCR studies.

Conclusion

Martin Ostermaier's contributions to GPCR research through his innovative patent and collaborative efforts have significantly advanced the field. His work continues to influence the understanding of molecular interactions and their applications in diagnostics and therapeutics.